Jerome D. Goldberg

Array ( [id] => 4118253 [patent_doc_number] => 06071882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Means for treating prostate hypertrophy and prostate cancer' [patent_app_type] => 1 [patent_app_number] => 9/062704 [patent_app_country] => US [patent_app_date] => 1998-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1923 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071882.pdf [firstpage_image] =>[orig_patent_app_number] => 062704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943967 [patent_doc_number] => 05990117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives' [patent_app_type] => 1 [patent_app_number] => 9/060443 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11531 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990117.pdf [firstpage_image] =>[orig_patent_app_number] => 060443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945970 [patent_doc_number] => 05998377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Means for treating prostate cancer' [patent_app_type] => 1 [patent_app_number] => 9/057458 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 1923 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998377.pdf [firstpage_image] =>[orig_patent_app_number] => 057458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409577 [patent_doc_number] => 06265386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Therapeutic use of D-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation' [patent_app_type] => 1 [patent_app_number] => 9/057065 [patent_app_country] => US [patent_app_date] => 1998-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 13520 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265386.pdf [firstpage_image] =>[orig_patent_app_number] => 057065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383484 [patent_doc_number] => 06262059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Method of treating a patient having precancerous lesions with quinazoline derivatives' [patent_app_type] => 1 [patent_app_number] => 9/055829 [patent_app_country] => US [patent_app_date] => 1998-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28699 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262059.pdf [firstpage_image] =>[orig_patent_app_number] => 055829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371307 [patent_doc_number] => 06277061 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Method of inhibiting membrane-type matrix metalloproteinase' [patent_app_type] => 1 [patent_app_number] => 9/052222 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8525 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277061.pdf [firstpage_image] =>[orig_patent_app_number] => 052222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028600 [patent_doc_number] => 05902830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Use of droloxifene for the treatment of cardiovascular disease' [patent_app_type] => 1 [patent_app_number] => 9/048568 [patent_app_country] => US [patent_app_date] => 1998-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1235 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902830.pdf [firstpage_image] =>[orig_patent_app_number] => 048568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179524 [patent_doc_number] => 06037337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects' [patent_app_type] => 1 [patent_app_number] => 9/046066 [patent_app_country] => US [patent_app_date] => 1998-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3484 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037337.pdf [firstpage_image] =>[orig_patent_app_number] => 046066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946616 [patent_doc_number] => 05998419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'N-(aminoalkyl)- and/or N-(amidoalkyl)-dinitrogen heterocycles' [patent_app_type] => 1 [patent_app_number] => 9/040787 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12569 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998419.pdf [firstpage_image] =>[orig_patent_app_number] => 040787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158589 [patent_doc_number] => 06156789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Method for treating abnormal cell proliferation in the brain' [patent_app_type] => 1 [patent_app_number] => 9/042992 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 0 [patent_no_of_words] => 14663 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156789.pdf [firstpage_image] =>[orig_patent_app_number] => 042992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157918 [patent_doc_number] => 06156755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures' [patent_app_type] => 1 [patent_app_number] => 9/038156 [patent_app_country] => US [patent_app_date] => 1998-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3241 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 991 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156755.pdf [firstpage_image] =>[orig_patent_app_number] => 038156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249193 [patent_doc_number] => 06221873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Cyclin dependent kinase inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/034581 [patent_app_country] => US [patent_app_date] => 1998-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 12 [patent_no_of_words] => 4216 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221873.pdf [firstpage_image] =>[orig_patent_app_number] => 034581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147301 [patent_doc_number] => 06063780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Method of treating a tumor' [patent_app_type] => 1 [patent_app_number] => 9/031692 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4970 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063780.pdf [firstpage_image] =>[orig_patent_app_number] => 031692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134582 [patent_doc_number] => 06121320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Combination anti-leukemic therapy by utilizing suramin and biologic response modifiers' [patent_app_type] => 1 [patent_app_number] => 9/031037 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9681 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121320.pdf [firstpage_image] =>[orig_patent_app_number] => 031037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4090420 [patent_doc_number] => 06133312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Method of suppressing tumor growth with combinations of isoprenoids and statins' [patent_app_type] => 1 [patent_app_number] => 9/027546 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 9001 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133312.pdf [firstpage_image] =>[orig_patent_app_number] => 027546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406956 [patent_doc_number] => 06232312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides' [patent_app_type] => 1 [patent_app_number] => 9/027334 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17980 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 394 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232312.pdf [firstpage_image] =>[orig_patent_app_number] => 027334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260516 [patent_doc_number] => 06204266 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties' [patent_app_type] => 1 [patent_app_number] => 8/930439 [patent_app_country] => US [patent_app_date] => 1998-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3975 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204266.pdf [firstpage_image] =>[orig_patent_app_number] => 930439 [rel_patent_id] =>[rel_patent_doc_number] =>)